EditorialKommentar
Cerebral Amyloid Angiopathy Diagnostic Criteria and Risk of Overdiagnosis
Stroke · 2023
DOI: 10.1161/strokeaha.123.043530 ↗Kurz gefasst
Editorial in der Zeitschrift Stroke, 2023. Verfasst von Matthew B Maas. Beteiligte Einrichtung: Departments of Neurology and Anesthesiology, Northwestern University, Chicago, IL. Hauptthemen laut MEDLINE: Stroke, Cerebral Amyloid Angiopathy. Die Arbeit nennt 16 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
StrokeCerebral Amyloid AngiopathyHumansOverdiagnosisCerebral HemorrhageMagnetic Resonance Imaging
Stichwörter der Autor:innen
Editorialsangiopathyatrial fibrillationriskstroke
Autor:innen und Institutionen
- Departments of Neurology and Anesthesiology, Northwestern University, Chicago, IL.
ORCID-Profile: Matthew B Maas
Zitieren
APA
Maas, M. B. (2023). Cerebral Amyloid Angiopathy Diagnostic Criteria and Risk of Overdiagnosis. Stroke. https://doi.org/10.1161/strokeaha.123.043530
Vancouver
Maas MB. Cerebral Amyloid Angiopathy Diagnostic Criteria and Risk of Overdiagnosis. Stroke. 2023. doi:10.1161/strokeaha.123.043530
BibTeX
@article{Maas2023,
author = {Maas, Matthew B},
title = {Cerebral Amyloid Angiopathy Diagnostic Criteria and Risk of Overdiagnosis},
journal = {Stroke},
year = {2023},
doi = {10.1161/strokeaha.123.043530}
}
EUVIMED